Newsroom
Sorted by: Latest
-
ONELIFE Senior Living Goes All in on SafelyYou Even Before Pilot Concludes
SAN FRANCISCO--(BUSINESS WIRE)--ONELIFE Senior Living, a provider dedicated to wholeheartedly supporting, enhancing, and empowering the lives of each resident, colleague, and family they serve, announced they are going all in across their portfolio with SafelyYou, the leader in empowering safer, more person-centered care across senior living through proven AI, industry-changing hardware, and remote expert clinicians. The decision was made even before the pilot concluded, and expands SafelyYou t...
-
Mercury Launches Premium Consumer Banking* for Builders and Founders
SAN FRANCISCO--(BUSINESS WIRE)--Mercury, the fintech that provides radically different banking* for over 200,000 ambitious companies and individuals, today announced the general availability of Mercury Personal. The personal account offers features that allow builders and founders to manage money the way they want to: with shared access and customizable permissions, competitive high-yield savings and investments, and seamless money movement — all with one annual subscription. Mercury has now op...
-
Elcano, Raptive, and Index Exchange Launch Raptive Unison to Bring Exclusive Creator Audiences to CTV and Beyond
NEW YORK--(BUSINESS WIRE)--Elcano today announced a strategic partnership with Raptive, the creator media company, and Index Exchange, one of the world’s largest independent supply-side platforms. The collaboration marks the launch of Raptive Unison, a curation product that gives advertisers access to Raptive’s verified, high-quality audiences across programmatic channels, including Connected TV (CTV). By aligning with Elcano and leveraging the infrastructure and sell-side decisioning capabilit...
-
FDA Approves USAntibiotics' Augmentin XR in Historic First for Expedited Review Program
BRISTOL, Tenn.--(BUSINESS WIRE)--USAntibiotics, the country's only domestic manufacturer of amoxicillin (Amoxil®) and amoxicillin clavulanate (Augmentin®), announced today that the U.S. Food and Drug Administration (FDA) has approved Augmentin XR (amoxicillin-clavulanate potassium) under the Commissioner's National Priority Voucher (CNPV) pilot program. The FDA’s re-approval marks the first drug approved through the CNPV expedited pathway and returns a critical extended-release antibiotic formu...
-
NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly Potent and Selective, Orally Bioavailable CDK2/4 Dual Degrader for Cancer Therapy at SABCS 2025
WILMINGTON, Del.--(BUSINESS WIRE)--NiKang Therapeutics Inc. (“NiKang”), a clinical stage biotech company focused on developing innovative small molecule oncology medicines to bring transformative therapies to patients in need, today announced the presentation of detailed preclinical data on NKT5097 at the 2025 San Antonio Breast Cancer Symposium (SABCS 2025) being held December 9-12, 2025, in San Antonio, TX. NKT5097 is a first-in-class, orally bioavailable small molecule engineered to selectiv...
-
New Listings Post Sharpest Drop in 2 Years, Tightening Housing Supply
SEATTLE--(BUSINESS WIRE)--New listings of U.S. homes for sale fell 1.7% year over year during the four weeks ending December 7, the biggest decline in over two years. That’s according to a new report from Redfin, the real estate brokerage powered by Rocket. Would-be home sellers are pulling back partly because it’s the end of the year, typically a slow season for the housing market, and partly because they’re reacting to lackluster homebuying demand. Pending home sales are down 4.1% from a year...
-
Senzing Acquires Placekey™ Service and Technology
LAS VEGAS--(BUSINESS WIRE)--Senzing, the leader in real-time entity resolution, today announced the acquisition of Placekey, the universal standard identifier for places data. This acquisition aligns with the Senzing mission to make data interoperable, better connected, and more valuable for organizations around the world. As a free, universal identifier, Placekey simplifies how organizations match, analyze, and enrich location data—eliminating much of the friction typically associated with dat...
-
Byline Bancorp Announces Approval of New Stock Repurchase Program
CHICAGO--(BUSINESS WIRE)--Byline Bancorp, Inc. (“Byline” or the “Company”) (NYSE: BY), announced today that its Board of Directors has approved a new stock repurchase program that authorizes the Company to repurchase up to 2.25 million shares of the Company’s outstanding common stock. The shares authorized to be repurchased represent approximately 4.9% of the Company’s currently outstanding common stock. The new program will be effective January 1, 2026 and be in effect until December 31, 2026....
-
Tahoe Therapeutics Selects Parse Biosciences’ GigaLab to Generate 300 Million Single Cell Profiles for Large-Scale Perturbation Atlas
SEATTLE--(BUSINESS WIRE)--Tahoe Therapeutics Selects Parse Biosciences’ GigaLab to Generate 300 Million Single Cell Profiles for Large-Scale Perturbation Atlas...
-
WEBTOON Announces Significant Expansion of its Creator Programs in 2026 to Champion Talent and Fuel Creative Careers
LOS ANGELES--(BUSINESS WIRE)--WEBTOON Entertainment Inc. (Nasdaq: WBTN), a global entertainment company and home to some of the world’s largest storytelling platforms, today announced a major expansion of its Creator Programs in 2026, offering more tools, support, and new opportunities to build a career on WEBTOON. Rolling out throughout 2026, WEBTOON’s new suite of Creator support initiatives will include expanded monetization opportunities, new convention and event support, and new educationa...